Annual Net Income
-$7.79 M
+$431.80 K+5.25%
31 December 2023
Summary:
Evoke Pharma annual net profit is currently -$7.79 million, with the most recent change of +$431.80 thousand (+5.25%) on 31 December 2023. During the last 3 years, it has risen by +$5.36 million (+40.76%). EVOK annual net income is now -286.24% below its all-time high of -$2.02 million, reached on 31 December 2012.EVOK Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$1.31 M
-$45.20 K-3.57%
30 September 2024
Summary:
Evoke Pharma quarterly net profit is currently -$1.31 million, with the most recent change of -$45.20 thousand (-3.57%) on 30 September 2024. Over the past year, it has increased by +$381.50 thousand (+22.52%). EVOK quarterly net income is now -447.06% below its all-time high of -$239.90 thousand, reached on 30 June 2013.EVOK Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$6.15 M
+$381.50 K+5.84%
30 September 2024
Summary:
Evoke Pharma TTM net profit is currently -$6.15 million, with the most recent change of +$381.50 thousand (+5.84%) on 30 September 2024. Over the past year, it has increased by +$1.46 million (+19.21%). EVOK TTM net income is now -1128.87% below its all-time high of -$500.20 thousand, reached on 31 March 2012.EVOK TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVOK Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.3% | +22.5% | +19.2% |
3 y3 years | +40.8% | +33.4% | +32.7% |
5 y5 years | -3.0% | +19.4% | +17.7% |
EVOK Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +40.8% | -3.6% | +41.5% | at high | +32.7% |
5 y | 5 years | -9.3% | +40.8% | -3.6% | +81.2% | at high | +56.0% |
alltime | all time | -286.2% | +41.2% | -447.1% | +81.2% | -1128.9% | +56.0% |
Evoke Pharma Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$1.31 M(+3.6%) | -$6.15 M(-5.8%) |
June 2024 | - | -$1.27 M(-19.8%) | -$6.53 M(-8.4%) |
Mar 2024 | - | -$1.58 M(-20.5%) | -$7.13 M(-8.5%) |
Dec 2023 | -$7.79 M(-5.3%) | -$1.99 M(+17.3%) | -$7.79 M(+2.4%) |
Sept 2023 | - | -$1.69 M(-9.3%) | -$7.61 M(-4.0%) |
June 2023 | - | -$1.87 M(-16.7%) | -$7.93 M(-4.4%) |
Mar 2023 | - | -$2.24 M(+24.4%) | -$8.29 M(+0.8%) |
Dec 2022 | -$8.22 M(-3.7%) | -$1.80 M(-10.5%) | -$8.22 M(+1.6%) |
Sept 2022 | - | -$2.01 M(-9.8%) | -$8.09 M(+0.6%) |
June 2022 | - | -$2.23 M(+2.7%) | -$8.05 M(-0.7%) |
Mar 2022 | - | -$2.17 M(+30.0%) | -$8.11 M(-5.1%) |
Dec 2021 | -$8.54 M(-35.1%) | -$1.67 M(-15.1%) | -$8.54 M(-6.5%) |
Sept 2021 | - | -$1.97 M(-14.0%) | -$9.13 M(-1.7%) |
June 2021 | - | -$2.29 M(-12.1%) | -$9.29 M(-33.5%) |
Mar 2021 | - | -$2.61 M(+14.9%) | -$13.97 M(+6.2%) |
Dec 2020 | -$13.15 M(+84.6%) | -$2.27 M(+6.5%) | -$13.15 M(+6.9%) |
Sept 2020 | - | -$2.13 M(-69.4%) | -$12.30 M(+4.2%) |
June 2020 | - | -$6.97 M(+289.2%) | -$11.80 M(+69.8%) |
Mar 2020 | - | -$1.79 M(+26.2%) | -$6.95 M(-2.5%) |
Dec 2019 | -$7.13 M(-5.8%) | -$1.42 M(-12.9%) | -$7.13 M(-4.6%) |
Sept 2019 | - | -$1.63 M(-23.0%) | -$7.47 M(+1.5%) |
June 2019 | - | -$2.11 M(+7.6%) | -$7.36 M(-2.5%) |
Mar 2019 | - | -$1.97 M(+11.6%) | -$7.55 M(-0.2%) |
Dec 2018 | -$7.57 M | -$1.76 M(+15.9%) | -$7.57 M(+23.8%) |
Sept 2018 | - | -$1.52 M(-34.0%) | -$6.11 M(-37.9%) |
June 2018 | - | -$2.30 M(+16.2%) | -$9.84 M(+7.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | -$1.98 M(+542.9%) | -$9.16 M(-25.1%) |
Dec 2017 | -$12.23 M(+13.8%) | -$308.40 K(-94.1%) | -$12.23 M(-9.1%) |
Sept 2017 | - | -$5.24 M(+222.5%) | -$13.45 M(+19.7%) |
June 2017 | - | -$1.63 M(-67.8%) | -$11.23 M(-10.7%) |
Mar 2017 | - | -$5.05 M(+230.8%) | -$12.58 M(+17.0%) |
Dec 2016 | -$10.75 M(-11.3%) | -$1.53 M(-49.5%) | -$10.75 M(-9.3%) |
Sept 2016 | - | -$3.03 M(+1.8%) | -$11.85 M(+2.5%) |
June 2016 | - | -$2.97 M(-7.9%) | -$11.56 M(-2.3%) |
Mar 2016 | - | -$3.23 M(+22.9%) | -$11.83 M(-2.4%) |
Dec 2015 | -$12.12 M(-8.5%) | -$2.62 M(-4.1%) | -$12.12 M(-2.4%) |
Sept 2015 | - | -$2.74 M(-15.6%) | -$12.42 M(-8.1%) |
June 2015 | - | -$3.24 M(-7.9%) | -$13.51 M(-2.2%) |
Mar 2015 | - | -$3.52 M(+20.6%) | -$13.81 M(+4.3%) |
Dec 2014 | -$13.25 M(+367.0%) | -$2.92 M(-23.7%) | -$13.25 M(+10.9%) |
Sept 2014 | - | -$3.83 M(+7.8%) | -$11.94 M(+38.8%) |
June 2014 | - | -$3.55 M(+20.0%) | -$8.61 M(+62.4%) |
Mar 2014 | - | -$2.96 M(+82.8%) | -$5.30 M(+86.8%) |
Dec 2013 | -$2.84 M(+40.6%) | -$1.62 M(+232.7%) | -$2.84 M(+49.9%) |
Sept 2013 | - | -$485.90 K(+102.5%) | -$1.89 M(-0.0%) |
June 2013 | - | -$239.90 K(-51.4%) | -$1.89 M(-5.9%) |
Mar 2013 | - | -$494.00 K(-26.5%) | -$2.01 M(-0.3%) |
Dec 2012 | -$2.02 M(-16.0%) | -$672.40 K(+38.3%) | -$2.02 M(+50.0%) |
Sept 2012 | - | -$486.30 K(+35.6%) | -$1.35 M(+56.6%) |
June 2012 | - | -$358.70 K(-28.3%) | -$858.90 K(+71.7%) |
Mar 2012 | - | -$500.20 K | -$500.20 K |
Dec 2011 | -$2.40 M | - | - |
FAQ
- What is Evoke Pharma annual net profit?
- What is the all time high annual net income for Evoke Pharma?
- What is Evoke Pharma annual net income year-on-year change?
- What is Evoke Pharma quarterly net profit?
- What is the all time high quarterly net income for Evoke Pharma?
- What is Evoke Pharma quarterly net income year-on-year change?
- What is Evoke Pharma TTM net profit?
- What is the all time high TTM net income for Evoke Pharma?
- What is Evoke Pharma TTM net income year-on-year change?
What is Evoke Pharma annual net profit?
The current annual net income of EVOK is -$7.79 M
What is the all time high annual net income for Evoke Pharma?
Evoke Pharma all-time high annual net profit is -$2.02 M
What is Evoke Pharma annual net income year-on-year change?
Over the past year, EVOK annual net profit has changed by +$431.80 K (+5.25%)
What is Evoke Pharma quarterly net profit?
The current quarterly net income of EVOK is -$1.31 M
What is the all time high quarterly net income for Evoke Pharma?
Evoke Pharma all-time high quarterly net profit is -$239.90 K
What is Evoke Pharma quarterly net income year-on-year change?
Over the past year, EVOK quarterly net profit has changed by +$381.50 K (+22.52%)
What is Evoke Pharma TTM net profit?
The current TTM net income of EVOK is -$6.15 M
What is the all time high TTM net income for Evoke Pharma?
Evoke Pharma all-time high TTM net profit is -$500.20 K
What is Evoke Pharma TTM net income year-on-year change?
Over the past year, EVOK TTM net profit has changed by +$1.46 M (+19.21%)